Dr. Elliott Fegelman Appointed VP of Medical Affairs at Kaleidoscope Innovation

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

August 28, 2019

Dr. Elliott Fegelman has been appointed the new VP of Medical Affairs of Kaleidoscope Innovation.

Dr. Elliott Fegelman brings over 20 years of experience as a medical and clinical leader for surgical product development to help ensure end-user perspectives remain central to the development of leading device solutions.

Fegelman is an expert clinician with success translating unmet needs at the bedside and in the OR to commercially viable products and services.

“The addition of Dr. Fegelman to the Kaleidoscope team means we can incorporate clinical user feedback throughout the development process in an even more efficient way,” said Dr. Michael Clem, VP of Research & Development for Kaleidoscope Innovation. “His extensive experience in medical affairs has the potential to decrease clinical risk and increase commercial readiness for our clients.”

Fegelman most recently served as Vice President and Therapeutic Area Expert at Johnson & Johnson Medical Devices focusing on the Ethicon business, a leading manufacturer of surgical technologies and solutions based in Cincinnati, OH. In this position, Fegelman was integral in shaping the company’s medical affairs, clinical research, business development, thought-leader engagement and training programs.

Prior to joining Ethicon, Fegelman served as the Chief of Surgery at The Cincinnati Jewish Hospital. There, Fegelman led the entire clinical and academic surgical service line at a tertiary teaching hospital. He was responsible for faculty recruitment and retention, curriculum development, credentialing of medical staff and clinical quality assurance.

Fegelman is excited about joining Kaleidoscope, where the user is central to product development. “At Kaleidoscope, I can partner with medical device manufacturers to help them understand what really matters in clinical practice and what is required for regulatory acceptance,” explained Fegelman. “This real-world experience is critical throughout the product development process, in risk assessment, during commercialization and when evaluating the acquisition of new technologies.”

Fegelman earned his medical degree from Wright State University, School of Medicine in Dayton, OH, following his graduation from Denison University. He completed his residency and chief residency in surgery at the University of Cincinnati.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.